| Kaleena Crooks, NP | |
|
202 Pomfret St, Putnam, CT 06260-1833 | |
| (860) 963-7917 | |
| (860) 963-0015 |
| Full Name | Kaleena Crooks |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 202 Pomfret St, Putnam, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639717408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 12681 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Providence Community Health Centers Inc. | 9335050962 | 88 |
News Archive
Identification of a molecular communications pathway that influences the mobilization of hematopoietic (blood) stem cells could lead to targeted therapies for improving bone marrow transplant success rates.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a universally fatal neurodegenerative disease. Mutations in two related proteins, TDP-43 and FUS, cause some forms of ALS. Specifically, these two proteins are RNA-binding proteins that connect to RNA to regulate the translation of proteins and other cellular functions such as RNA splicing and editing. In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania discovered additional human genes with properties similar to TDP-43 and FUS that might also contribute to ALS.
Qosina is pleased to announce the addition of eight new barbed check valves to complement their extensive line of stock components. Available in three different configurations, these barbed valves have a low, 0.087 psi cracking pressure.
Douglas A. Mitchell, IGB faculty member in the Mining Microbial Genomes for Novel Antibiotics research theme and assistant professor in the Department of Chemistry, is a recipient of the 2011 National Institutes of Health Director's New Innovator Award. The award recognizes bold ideas from some of the nation's most promising new scientists.
› Verified 7 days ago
| Entity Name | The Providence Community Health Centers Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053313593 PECOS PAC ID: 9335050962 Enrollment ID: O20040608000007 |
News Archive
Identification of a molecular communications pathway that influences the mobilization of hematopoietic (blood) stem cells could lead to targeted therapies for improving bone marrow transplant success rates.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a universally fatal neurodegenerative disease. Mutations in two related proteins, TDP-43 and FUS, cause some forms of ALS. Specifically, these two proteins are RNA-binding proteins that connect to RNA to regulate the translation of proteins and other cellular functions such as RNA splicing and editing. In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania discovered additional human genes with properties similar to TDP-43 and FUS that might also contribute to ALS.
Qosina is pleased to announce the addition of eight new barbed check valves to complement their extensive line of stock components. Available in three different configurations, these barbed valves have a low, 0.087 psi cracking pressure.
Douglas A. Mitchell, IGB faculty member in the Mining Microbial Genomes for Novel Antibiotics research theme and assistant professor in the Department of Chemistry, is a recipient of the 2011 National Institutes of Health Director's New Innovator Award. The award recognizes bold ideas from some of the nation's most promising new scientists.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaleena Crooks, NP 40 Mansfield Ave, Willimantic, CT 06226-2018 Ph: (860) 450-7471 | Kaleena Crooks, NP 202 Pomfret St, Putnam, CT 06260-1833 Ph: (860) 963-7917 |
News Archive
Identification of a molecular communications pathway that influences the mobilization of hematopoietic (blood) stem cells could lead to targeted therapies for improving bone marrow transplant success rates.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a universally fatal neurodegenerative disease. Mutations in two related proteins, TDP-43 and FUS, cause some forms of ALS. Specifically, these two proteins are RNA-binding proteins that connect to RNA to regulate the translation of proteins and other cellular functions such as RNA splicing and editing. In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania discovered additional human genes with properties similar to TDP-43 and FUS that might also contribute to ALS.
Qosina is pleased to announce the addition of eight new barbed check valves to complement their extensive line of stock components. Available in three different configurations, these barbed valves have a low, 0.087 psi cracking pressure.
Douglas A. Mitchell, IGB faculty member in the Mining Microbial Genomes for Novel Antibiotics research theme and assistant professor in the Department of Chemistry, is a recipient of the 2011 National Institutes of Health Director's New Innovator Award. The award recognizes bold ideas from some of the nation's most promising new scientists.
› Verified 7 days ago
Sara Cathleen Nickle, DNP, FNP-C, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 330 Pomfret St, Putnam, CT 06260 Phone: 860-928-2736 | |
Mrs. Jeanne Bedard, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 346 Pomfret St, Putnam, CT 06260 Phone: 860-928-0815 Fax: 860-928-4514 | |
Kimberly J Lane, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-6541 Fax: 860-963-6393 | |
Marissa Lahaie, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 330 Pomfret St, Putnam, CT 06260 Phone: 860-928-2736 | |
Mrs. Kerri Lynn Sauer, APRN-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Kennedy Dr, Putnam, CT 06260 Phone: 860-963-2133 | |
Ralph Frank Hirschfeld, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 202 Pomfret St, Putnam, CT 06260 Phone: 860-963-7917 Fax: 860-963-0015 | |
Annette Jakubisin-konicki, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-963-6390 Fax: 860-963-6343 |